{"id":18467,"date":"2021-03-05T10:25:34","date_gmt":"2021-03-05T09:25:34","guid":{"rendered":"https:\/\/asscat-hepatitis.org\/?p=18467"},"modified":"2021-03-05T10:25:34","modified_gmt":"2021-03-05T09:25:34","slug":"la-covid-19-pot-dificultar-leliminacio-de-lhepatitis-c-a-espanya","status":"publish","type":"post","link":"https:\/\/asscat-hepatitis.org\/ca\/la-covid-19-pot-dificultar-leliminacio-de-lhepatitis-c-a-espanya\/","title":{"rendered":"La COVID-19 pot dificultar l\u2019eliminaci\u00f3 de l\u2019hepatitis C a Espanya"},"content":{"rendered":"<p>[et_pb_section bb_built=&#8221;1&#8243; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;3.0.106&#8243; custom_margin=&#8221;|||&#8221; custom_padding=&#8221;0px||0px|&#8221; next_background_color=&#8221;#000000&#8243;][et_pb_row custom_padding=&#8221;0px||0px|&#8221; _builder_version=&#8221;3.0.106&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221;][et_pb_column type=&#8221;4_4&#8243;][et_pb_post_title author=&#8221;off&#8221; date_format=&#8221;d\/m\/Y&#8221; comments=&#8221;off&#8221; featured_placement=&#8221;background&#8221; text_background=&#8221;on&#8221; text_bg_color=&#8221;#ffffff&#8221; module_class=&#8221;ac-post-title-section-0&#8243; _builder_version=&#8221;3.0.106&#8243; title_font=&#8221;Montserrat|600|||||||&#8221; title_text_color=&#8221;#2d2d2d&#8221; title_letter_spacing=&#8221;-1px&#8221; title_line_height=&#8221;1.2em&#8221; meta_font=&#8221;Open Sans||||||||&#8221; meta_text_color=&#8221;rgba(45,45,45,0.5)&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;|||&#8221; custom_padding=&#8221;|20px|20px|20px&#8221; title_text_align=&#8221;center&#8221; meta_font_size=&#8221;13px&#8221; meta_text_align=&#8221;center&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_post_title][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section bb_built=&#8221;1&#8243; _builder_version=&#8221;3.0.106&#8243; custom_padding=&#8221;||0px|&#8221; prev_background_color=&#8221;#000000&#8243; module_class=&#8221;ac-post-section-share-rrss&#8221; next_background_color=&#8221;#000000&#8243;][et_pb_row custom_padding=&#8221;||0px|&#8221; custom_margin=&#8221;|||&#8221; _builder_version=&#8221;3.0.105&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221;][et_pb_column type=&#8221;4_4&#8243;][et_pb_divider color=&#8221;#e20611&#8243; show_divider=&#8221;on&#8221; divider_style=&#8221;ridge&#8221; _builder_version=&#8221;3.0.106&#8243; \/][et_pb_text _builder_version=&#8221;3.0.106&#8243; text_font=&#8221;Montserrat||||||||&#8221; text_text_color=&#8221;#e20611&#8243; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||0px|&#8221; custom_padding=&#8221;|||&#8221; background_layout=&#8221;light&#8221; disabled=&#8221;on&#8221;]<\/p>\n<h5>Desde aqu\u00ed puedes compartir esta publicaci\u00f3n. \u00a1Gracias!<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section bb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.0.106&#8243; custom_padding=&#8221;0px|||&#8221; prev_background_color=&#8221;#000000&#8243; disabled=&#8221;on&#8221;][et_pb_column type=&#8221;2_3&#8243; specialty_columns=&#8221;2&#8243;][et_pb_row_inner admin_label=&#8221;Fila&#8221; _builder_version=&#8221;3.0.106&#8243;][et_pb_column_inner type=&#8221;4_4&#8243; saved_specialty_column_type=&#8221;2_3&#8243;][et_pb_text admin_label=&#8221;Contenido Entrada 1&#8243; ul_type=&#8221;square&#8221; module_class=&#8221;ac-posts-content&#8221; _builder_version=&#8221;3.0.106&#8243; text_orientation=&#8221;justified&#8221; background_layout=&#8221;light&#8221;]<\/p>\n<h3>Gilead organitza \u2018Connecta, Comparteix, Construeix\u2019, un espai de debat que permeti l\u2019intercanvi de bones pr\u00e0ctiques.<\/h3>\n<p>Experts en hepatitis C (VHC) han ressaltat durant la primera sessi\u00f3 de la jornada<strong>\u00a0&#8216;Connecta, Comparteix, Construeix&#8217;<\/strong>, organitzada per Gilead, la necessitat de\u00a0<strong>diagnosticar i tractar a les poblacions d\u2019alta prevalen\u00e7a d\u2019hepatitis C\u00a0<\/strong>i escassa adher\u00e8ncia al sistema sanitari, com els<strong>\u00a0usuaris de drogues<\/strong>, per arribar a les metes de l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS) d\u2019eliminaci\u00f3 de l\u2019hepatitis C com a problema de salut mundial abans de l\u2019any 2030.<\/p>\n<p><em>\u201c<strong>Aquesta poblaci\u00f3 vulnerable requereix de circu\u00efts espec\u00edfics d\u2019assist\u00e8ncia que aconsegueixin la seva adher\u00e8ncia a consulta\u00a0<\/strong>i compliment del tractament\u201d<\/em>, ha ressaltat Paco P\u00e9rez, de l\u2019Hospital Universitari Nuestra Se\u00f1ora de la Candelaria a Tenerife.<\/p>\n<p>En la seva intervenci\u00f3, ha comptat la seva experi\u00e8ncia. <em>\u201cA Tenerife, l\u2019Hospital Nuestra Se\u00f1ora de la Candelaria i les Unitats d\u2019Atenci\u00f3 al Drogodependent (UADS) de San Miguel Addiccions i l\u2019Associaci\u00f3 Norte de Tenerife d\u2019Atenci\u00f3 a les Drogodepend\u00e8ncies (Antad) treballen amb\u00a0<strong>un equip interdisciplinari en el qual participen professionals de diverses \u00e0rees<\/strong>\u00a0(hepat\u00f2legs, farmac\u00e8utics, microbi\u00f2legs, treballadors socials, psic\u00f2legs i personal administratiu) que, connectant d\u2019igual a igual i compartint esfor\u00e7os i responsabilitats, han constru\u00eft un circu\u00eft d\u2019atenci\u00f3 centrat en la captaci\u00f3 i screening de pacients a les UADS, l\u2019estudi i prescripci\u00f3 del tractament en un sol dia a l\u2019hospital i el seguiment i monitoritzaci\u00f3 del tractament compartit. Gr\u00e0cies a aquest circu\u00eft hem comunicat, internacionalment, <strong>resultats extraordinaris amb adher\u00e8ncia i taxes de curaci\u00f3 superiors al 90%<\/strong>\u201d<\/em>, ha argumentat.<\/p>\n<p><strong>La pand\u00e8mia de COVID-19 ha suposat un obstacle en l\u2019eliminaci\u00f3 de l\u2019hepatitis <\/strong>i en altres programes sanitaris. Aix\u00f2 ja t\u00e9 conseq\u00fc\u00e8ncies en la salut individual dels pacients i en la salut p\u00fablica al permetre noves infeccions. <em>\u201cEn el cas particular de Tenerife, l\u2019Hospital Nuestra Se\u00f1ora de Candelaria i les UADS de San Miguel Addiccionsiy Antad han aconseguit mantenir obert el programa d\u2019eliminaci\u00f3 afegint al circu\u00eft ja utilitzat dues noves estrat\u00e8gies: la telemedicina (tel\u00e8fon i email) i la farm\u00e0cia compartida amb dispensaci\u00f3 del tractament des de la UADS. Malgrat una reducci\u00f3 significativa en el n\u00famero de pacients tractats, en part pels esfor\u00e7os previs d\u2019eliminaci\u00f3, s\u2019ha aconseguit mantenir les extraordin\u00e0ries taxes de curaci\u00f3\u201d<\/em>, ha indicat P\u00e9rez.<\/p>\n<h3>Import\u00e0ncia del \u2018screening\u2019 a Urg\u00e8ncies<\/h3>\n<p>A m\u00e9s d\u2019aconseguir el diagn\u00f2stic i tractament en els usuaris de drogues, l\u2019\u00e0rea d\u2019Urg\u00e8ncies d\u2019un hospital tamb\u00e9 \u00e9s un lloc clau pel cribratge dels pacients amb hepatitis C. <em>\u201c<strong>Tenim un objectiu m\u00e9s ambici\u00f3s que la curaci\u00f3 de l\u2019hepatitis C i \u00e9s aconseguir un hospital lliure del virus.<\/strong>\u00a0Una forma de fer-ho \u00e9s fer cribratge a tots els pacients que ingressaran a l\u2019hospital de forma que les urg\u00e8ncies es converteixin en una de les majors fronteres contra el VHC. Es tracta d\u2019un projecte ambici\u00f3s i transversal que permet a moltes persones de diferents \u00e0rees con\u00e8ixer estrat\u00e8gies de cribratge i conscienciar sobre la infecci\u00f3 silent d\u2019aquest virus\u201d<\/em>, ha apuntat Jordi Llaneras, de l\u2019Hospital Universitari Vall d&#8217;Hebron de Barcelona.<\/p>\n<p>A m\u00e9s, ha senyalat que <em>\u201caquesta estrat\u00e8gia, a banda de\u00a0<strong>permetre un cribratge de tota una \u00e0rea sanit\u00e0ria<\/strong>, ha perm\u00e8s &#8216;treure&#8217; de les consultes externes d\u2019hepatologia el VHC i visibilitzar-lo com una patologia potencialment greu que tenen els pacients d\u2019urg\u00e8ncies, educant aix\u00ed a metges d\u2019altres especialitats per a qu\u00e8 siguin conscients de la rellev\u00e0ncia d\u2019aquesta infecci\u00f3\u201d<\/em>.<\/p>\n<p><em>\u201cAix\u00ed mateix, es tracta d\u2019<strong>un projecte que ha perm\u00e8s accedir a aquelles poblacions amb esc\u00e0s contacte amb la medicina ambulat\u00f2ria<\/strong>\u00a0(asils, problem\u00e0tica social, immigrants, etc.) sent visibilitats i tractats, encara que actualment ja haur\u00edem de dir directament, ser curats\u201d<\/em>, ha afegit.<\/p>\n<h3>\u201cConnecta, comparteix i construeix\u201d per eliminar l\u2019hepatitis C<\/h3>\n<p>Gilead ha organitzat la primera sessi\u00f3 del projecte &#8216;Connecta, Comparteix, Construeix&#8217; amb la finalitat de crear\u00a0<strong>un espai de debat que permeti l\u2019intercanvi de bones pr\u00e0ctiques identificades per tot el territori nacional\u00a0<\/strong>i que permetin assolir l\u2019eliminaci\u00f3 de l\u2019hepatitis C. Una iniciativa que est\u00e0 avalada per l\u2019Alian\u00e7a per a l\u2019Eliminaci\u00f3 de les Hepatitis Virals (AEHVE) i per l\u2019Associaci\u00f3 Espanyola per a l\u2019Estudi del Fetge (AEEH).<\/p>\n<p>Aquesta iniciativa, avalada per l\u2019Alian\u00e7a per a l\u2019Eliminaci\u00f3 de les Hepatitis Virals (AEHVE) i l\u2019Associaci\u00f3 Espanyola per a l\u2019Estudi del Fetge (AEEH), pret\u00e9n ser un espai on un cop al mes, al llarg de tot l\u2019any, es comparteixen iniciatives alineades <strong>amb l\u2019objectiu de cerca de pacients perduts ja diagnosticats, i screening i simplificaci\u00f3 de circu\u00efts<\/strong>\u00a0en poblacions vulnerables d\u2019alta prevalen\u00e7a.<\/p>\n<p>La segona sessi\u00f3, que tindr\u00e0 lloc el proper 15 d\u2019abril i estar\u00e0 moderada per Javier Garc\u00eda-Samaniego, de l\u2019Hospital Universitari La Paz de Madrid i coordinador de l\u2019AEHVE, analitzar\u00e0 i debatr\u00e0 juntament amb Antonio Olveira, de l\u2019Hospital Universitari La Paz de Madrid, i Mar Sureda, de la Ger\u00e8ncia d\u2019Atenci\u00f3 Prim\u00e0ria de Mallorca, diferents estrat\u00e8gies que permetin seguir avan\u00e7ant en el cam\u00ed de l\u2019eliminaci\u00f3 de l\u2019hepatitis C.<\/p>\n<p><em>\u201cEs tracta d\u2019una nova iniciativa per <strong>con\u00e8ixer i compartir diverses experi\u00e8ncies en l\u2019eliminaci\u00f3 de l\u2019hepatitis C al nostre medi.<\/strong>\u00a0S\u00f3n experi\u00e8ncies constructives, que podem incorporar a la nostra pr\u00e0ctica cl\u00ednica i sobretot van dirigides a millorar el cribratge i la vinculaci\u00f3 a la cura. S\u00f3n experi\u00e8ncies d\u2019\u00e8xit que ajuden a la microeliminaci\u00f3, el primer pas per aconseguir l\u2019objectiu de l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS) d\u2019eliminar les hepatitis v\u00edriques com una amena\u00e7a per a la salut p\u00fablica pel 2030. Els objectius s\u00f3n reduir la incid\u00e8ncia del virus de l\u2019hepatitis C en un 80% i la mortalitat relacionada amb el VHC en un 65% pel 2030 (en comparaci\u00f3 amb el 2015)\u201d<\/em>, ha comentat la moderadora, Mar\u00eda Buti, de l\u2019Hospital Universitari Vall d&#8217;Hebron de Barcelona.<\/p>\n<p>&nbsp;<\/p>\n<p>Font: <a href=\"https:\/\/www.redaccionmedica.com\/secciones\/industria\/el-covid-19-es-un-gran-obstaculo-para-erradicar-la-hepatitis-c-en-espana-1039\">redaccionmedica.com<\/a><\/p>\n<p>Not\u00edcia tradu\u00efda per l\u2019ASSCAT<\/p>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Contenido Entrada 1&#8243; ul_type=&#8221;square&#8221; module_class=&#8221;ac-posts-content&#8221; _builder_version=&#8221;3.0.106&#8243; text_orientation=&#8221;justified&#8221; background_layout=&#8221;light&#8221; \/][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner admin_label=&#8221;Fila&#8221; custom_padding=&#8221;0px|||&#8221; _builder_version=&#8221;3.0.105&#8243; custom_margin=&#8221;|||&#8221;][et_pb_column_inner type=&#8221;4_4&#8243; saved_specialty_column_type=&#8221;2_3&#8243;][et_pb_post_title admin_label=&#8221;Metadatos &#8211; Fecha \u00daltima actualizaci\u00f3n&#8221; title=&#8221;off&#8221; author=&#8221;off&#8221; date_format=&#8221;d\/m\/Y&#8221; categories=&#8221;off&#8221; comments=&#8221;off&#8221; featured_image=&#8221;off&#8221; _builder_version=&#8221;3.0.106&#8243; title_text_align=&#8221;left&#8221; meta_font=&#8221;Open Sans||||||||&#8221; meta_text_align=&#8221;left&#8221; meta_font_size=&#8221;13px&#8221; meta_text_color=&#8221;#0082ca&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#cccccc&#8221; custom_margin=&#8221;50px|||&#8221; custom_padding=&#8221;10px|||&#8221; custom_css_before=&#8221;content:%22\u00daltima actualizaci\u00f3n:%22;&#8221; global_module=&#8221;3449&#8243; saved_tabs=&#8221;all&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_post_title][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243;][et_pb_sidebar orientation=&#8221;right&#8221; area=&#8221;et_pb_widget_area_8&#8243; module_class=&#8221;ac-posts-sidebar&#8221; _builder_version=&#8221;3.0.106&#8243; global_module=&#8221;3198&#8243; saved_tabs=&#8221;all&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_sidebar][\/et_pb_column][\/et_pb_section]<\/p>\n<!-- Begin Yuzo --><div class='yuzo_related_post style-1'  data-version='5.12.77'><!-- without result --><div class='yuzo_clearfixed yuzo__title yuzo__title'><h3>Related Post<\/h3><\/div>\n\t\t\t\t\t\t  <div class=\"relatedthumb \" style=\"width:125px;float:left;overflow:hidden;\">  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <a  href=\"https:\/\/asscat-hepatitis.org\/ca\/entrevista-amb-el-dr-francisco-rodriguez-frias-cap-de-seccio-de-les-arees-especials-de-bioquimica-clinica-i-responsable-de-la-unitat-de-patologia-hepatica-dels-serveis-de-bioquimica-i-microbiologia\/\"  >\n\t\t\t\t\t\t\t\t\t  <div class=\"yuzo-img-wrap \" style=\"width: 125px;height:90px;\">\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"yuzo-img\" style=\"background:url('https:\/\/asscat-hepatitis.org\/wp-content\/uploads\/fco-rodriguez-frias-150x150.jpeg') 50% 50% no-repeat;width: 125px;height:90px;margin-bottom: 5px;background-size: cover; \"><\/div>\n\t\t\t\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t\t   <span class=\"yuzo__text--title\" style=\"font-size:13px;\">Entrevista amb el Dr. Francisco Rodr\u00edguez Fr\u00edas, C...<\/span>\n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <\/a>\n\n\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t  <div class=\"relatedthumb \" style=\"width:125px;float:left;overflow:hidden;\">  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <a  href=\"https:\/\/asscat-hepatitis.org\/ca\/combinacions-de-farmacs-pangenotipics-contra-lhepatitis-c-curen-a-gairebe-totes-les-persones-que-completen-el-tractament-segons-estudis-de-la-vida-real\/\"  >\n\t\t\t\t\t\t\t\t\t  <div class=\"yuzo-img-wrap \" style=\"width: 125px;height:90px;\">\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"yuzo-img\" style=\"background:url('https:\/\/asscat-hepatitis.org\/wp-content\/uploads\/pangenotipicos-150x150.jpg') 50% 50% no-repeat;width: 125px;height:90px;margin-bottom: 5px;background-size: cover; \"><\/div>\n\t\t\t\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t\t   <span class=\"yuzo__text--title\" style=\"font-size:13px;\">Combinacions de f\u00e0rmacs pangenot\u00edpics contra l\u2019hep...<\/span>\n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <\/a>\n\n\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t  <div class=\"relatedthumb \" style=\"width:125px;float:left;overflow:hidden;\">  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <a  href=\"https:\/\/asscat-hepatitis.org\/ca\/el-treball-en-xarxa-permet-abordar-les-malalties-hepatiques-minoritaries\/\"  >\n\t\t\t\t\t\t\t\t\t  <div class=\"yuzo-img-wrap \" style=\"width: 125px;height:90px;\">\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"yuzo-img\" style=\"background:url('https:\/\/asscat-hepatitis.org\/wp-content\/uploads\/foto-1-5-150x150.jpg') 50% 50% no-repeat;width: 125px;height:90px;margin-bottom: 5px;background-size: cover; \"><\/div>\n\t\t\t\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t\t   <span class=\"yuzo__text--title\" style=\"font-size:13px;\">El treball en xarxa permet abordar les malalties h...<\/span>\n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <\/a>\n\n\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t  <div class=\"relatedthumb \" style=\"width:125px;float:left;overflow:hidden;\">  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <a  href=\"https:\/\/asscat-hepatitis.org\/ca\/la-comunitat-de-madrid-demora-injustificadament-els-cribratges-en-hepatitis-c\/\"  >\n\t\t\t\t\t\t\t\t\t  <div class=\"yuzo-img-wrap \" style=\"width: 125px;height:90px;\">\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"yuzo-img\" style=\"background:url('https:\/\/asscat-hepatitis.org\/wp-content\/uploads\/madrid-cribado-150x150.jpg') 50% 50% no-repeat;width: 125px;height:90px;margin-bottom: 5px;background-size: cover; \"><\/div>\n\t\t\t\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t\t   <span class=\"yuzo__text--title\" style=\"font-size:13px;\">La Comunitat de Madrid demora injustificadament el...<\/span>\n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <\/a>\n\n\t\t\t\t\t\t  <\/div>\n<\/div> <style>\n\t\t\t\t\t\t\t\t.yuzo_related_post img{width:120px !important; height:110px !important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb{line-height:15px;background: !important;color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb:hover{background:#fcfcf4 !important; -webkit-transition: background 0.2s linear; -moz-transition: background 0.2s linear; -o-transition: background 0.2s linear; transition: background 0.2s linear;;color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb a{color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb a:hover{ color:}!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb:hover a{ color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .yuzo_text {color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb:hover .yuzo_text {color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb{  margin: 0px  0px  0px  0px;   padding: 5px  5px  5px  5px;  }\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/style> <script>\n\t\t\t\t\t\t  jQuery(document).ready(function( $ ){\n\t\t\t\t\t\t\t\/\/jQuery('.yuzo_related_post').equalizer({ overflow : 'relatedthumb' });\n\t\t\t\t\t\t\tjQuery('.yuzo_related_post .yuzo_wraps').equalizer({ columns : '> div' });\n\t\t\t\t\t\t   })\n\t\t\t\t\t\t  <\/script> <!-- End Yuzo :) -->","protected":false},"excerpt":{"rendered":"<p>Gilead organitza \u2018Connecta, Comparteix, Construeix\u2019, un espai de debat que permeti l\u2019intercanvi de bones pr\u00e0ctiques.<\/p>\n","protected":false},"author":9,"featured_media":18469,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[491],"tags":[3962,644,544,8073,8074,1307,3987,8069,3951,523,8075],"class_list":["post-18467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-de-prensa-ca","tag-abbvie-ca","tag-aeeh-ca","tag-aehve-ca","tag-cerca-pacients-perduts-ca","tag-dificultats-covid-19-ca","tag-eliminacio-hepatitis-c","tag-gilead-sciences-ca","tag-jornada-virtual-ca","tag-premsa-ca","tag-screening-ca","tag-simplificacio-circuits-ca"],"_links":{"self":[{"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/posts\/18467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/comments?post=18467"}],"version-history":[{"count":0,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/posts\/18467\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/media\/18469"}],"wp:attachment":[{"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/media?parent=18467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/categories?post=18467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/tags?post=18467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}